Skip to main content
High RiskFDAfda-F-1145-2018UNDECLARED ALLERGEN

Izzy's Ice Cream, Maple Nut, One Pint (473 ml), UPC 51115-00106. Izzy's Ice Cream, 1100 2nd Street S., Minneapolis, MN 55415.

Category
Units Affected
264
Recall Date
March 16, 2018
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1145-2018.

Izzy's is recalling Maple Nut ice cream after being notified by a supplier that they are recalling walnuts due to possible presence of undeclared peanut residue.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1145-2018.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Izzy's Ice Cream, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1145-2018.

Izzy's Ice Cream, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Izzy's Ice Cream, Llc Recall FAQ

Izzy's Ice Cream, Llc is the subject of a dairy safety report: Izzy's Ice Cream, Maple Nut, One Pint (473 ml), UPC 51115-00106. Izzy's Ice Cream, 1100 2nd Street S., Minneapolis, MN 55415.. The notice was published on March 16, 2018 by the U.S. Food and Drug Administration (FDA). Approximately 264 units are potentially affected.